Details for Patent: 12,128,010
Which drugs does patent 12,128,010 protect, and when does it expire?
Patent 12,128,010 protects MIEBO and is included in one NDA.
This patent has twenty patent family members in ten countries.
Summary for Patent: 12,128,010
| Title: | Semifluorinated compounds and their compositions |
| Abstract: | The present invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye. |
| Inventor(s): | Dieter Scherer, Ralf GRILLENBERGER, Frank LÖSCHER, Hartmut Voss |
| Assignee: | Novaliq GmbH |
| Application Number: | US17/833,836 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,128,010 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 12,128,010
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,128,010
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 108348777 | ⤷ Start Trial | |||
| China | 110403923 | ⤷ Start Trial | |||
| China | 111743882 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
